{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:43:04Z","timestamp":1771569784057,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00702-008-0136-2","type":"journal-article","created":{"date-parts":[[2008,10,29]],"date-time":"2008-10-29T10:53:18Z","timestamp":1225277598000},"page":"1651-1659","source":"Crossref","is-referenced-by-count":49,"title":["Effect of copper intake on CSF parameters in patients with mild Alzheimer\u2019s disease: a pilot phase\u00a02 clinical trial"],"prefix":"10.1007","volume":"115","author":[{"given":"Holger","family":"Kessler","sequence":"first","affiliation":[]},{"given":"Frank-Gerald","family":"Pajonk","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Bach","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Schneider-Axmann","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[]},{"given":"Wolfgang","family":"Herrmann","sequence":"additional","affiliation":[]},{"given":"Gerd","family":"Multhaup","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Stephanie","family":"Sch\u00e4fer","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Wirths","sequence":"additional","affiliation":[]},{"given":"Thomas A.","family":"Bayer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,10,30]]},"reference":[{"issue":"4","key":"136_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15622970310029912","volume":"4","author":"N Andreasen","year":"2003","unstructured":"Andreasen N, Sjogren M, Blennow K (2003) CSF markers for Alzheimer\u2019s disease: total tau, phospho-tau and Abeta42. World J Biol Psychiatry 4(4):147\u2013155","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"136_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","volume":"75","author":"CS Atwood","year":"2000","unstructured":"Atwood CS, Scarpa RC, Huang X, Moir RD et al (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1\u201342. J Neurochem 75(3):1219\u20131233","journal-title":"J Neurochem"},{"issue":"19","key":"136_CR3","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1074\/jbc.M300629200","volume":"278","author":"KJ Barnham","year":"2003","unstructured":"Barnham KJ, McKinstry WJ, Multhaup G, Galatis D et al (2003) Structure of the Alzheimer\u2019s disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. J Biol Chem 278(19):17401\u201317407","journal-title":"J Biol Chem"},{"issue":"1","key":"136_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2001.tb00376.x","volume":"11","author":"TA Bayer","year":"2001","unstructured":"Bayer TA, Wirths O, Majtenyi K, Hartmann T et al (2001) Key factors in Alzheimer\u2019s disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 11(1):1\u201311","journal-title":"Brain Pathol"},{"issue":"24","key":"136_CR4","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","volume":"100","author":"TA Bayer","year":"2003","unstructured":"Bayer TA, Sch\u00e4fer S, Simons A, Kemmling A et al (2003) Dietary Cu stabilizes brain SOD-1 activity and reduces amyoid A\u00df production in APP23 transgenic mice. Proc Natl Acad Sci USA 100(24):14187\u201314192","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"136_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/bj3440461","volume":"344","author":"T Borchardt","year":"1999","unstructured":"Borchardt T, Camakaris J, Cappai R, Masters CL et al (1999) Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J 344(Pt 2):461\u2013467","journal-title":"Biochem J"},{"issue":"4","key":"136_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","volume":"26","author":"AI Bush","year":"2003","unstructured":"Bush AI (2003) The metallobiology of Alzheimer\u2019s disease. Trends Neurosci 26(4):207\u2013214","journal-title":"Trends Neurosci"},{"issue":"3","key":"136_CR8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron 30(3):665\u2013676","journal-title":"Neuron"},{"issue":"1\u20132","key":"136_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","volume":"143","author":"MA Deibel","year":"1996","unstructured":"Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: possible relation to oxidative stress. J Neurol Sci 143(1\u20132):137\u2013142","journal-title":"J Neurol Sci"},{"key":"136_CR10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2032s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"136_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(94)00658-X","volume":"349","author":"L Hesse","year":"1994","unstructured":"Hesse L, Beher D, Masters CL, Multhaup G (1994) The beta A4 amyloid precursor protein binding to copper. Febs Lett 349(1):109\u2013116","journal-title":"Febs Lett"},{"issue":"5\u20136","key":"136_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000213037","volume":"35","author":"C Jeandel","year":"1989","unstructured":"Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F et al (1989) Lipid peroxidation and free radical scavengers in Alzheimer\u2019s disease. Gerontology 35(5\u20136):275\u2013282","journal-title":"Gerontology"},{"key":"136_CR13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM et al (1987) The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733\u2013736","journal-title":"Nature"},{"issue":"5","key":"136_CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00115-004-1849-6","volume":"76","author":"H Kessler","year":"2005","unstructured":"Kessler H, Pajonk FG, Supprian T, Falkai P et al (2005) [The role of copper in the pathophysiology of Alzheimer\u2019s disease.]. Nervenarzt 76(5):581\u2013585","journal-title":"Nervenarzt"},{"issue":"11","key":"136_CR15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00702-006-0485-7","volume":"113","author":"H Kessler","year":"2006","unstructured":"Kessler H, Pajonk FG, Meisser P, Schneider-Axmann T et al (2006) Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer\u2019s disease. J Neural Transm 113(11):1763\u20131769","journal-title":"J Neural Transm"},{"issue":"8","key":"136_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00702-008-0080-1","volume":"115","author":"H Kessler","year":"2008","unstructured":"Kessler H, Bayer TA, Bach D, Schneider-Axmann T et al (2008) Intake of copper has no effect on cognition in patients with mild Alzheimer\u2019s disease\u2014a pilot phase 2 clinical trial. J Neural Transm 115(8):1181\u20131187","journal-title":"J Neural Transm"},{"issue":"3","key":"136_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Otto M, Maler JM et al (2004) Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF Abeta42, Abeta42\/Abeta40 ratio and total tau. Neurobiol Aging 25(3):273\u2013281","journal-title":"Neurobiol Aging"},{"issue":"2","key":"136_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(96)00782-2","volume":"738","author":"DA Loeffler","year":"1996","unstructured":"Loeffler DA, LeWitt PA, Juneau PL, Sima AA et al (1996) Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738(2):265\u2013274","journal-title":"Brain Res"},{"issue":"1","key":"136_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell MA, Robertson JD, Teesdale WJ, Campbell JL et al (1998) Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 158(1):47\u201352","journal-title":"J Neurol Sci"},{"issue":"47","key":"136_CR20","doi-asserted-by":"crossref","first-page":"44670","DOI":"10.1074\/jbc.M204379200","volume":"277","author":"CJ Maynard","year":"2002","unstructured":"Maynard CJ, Cappai R, Volitakis I, Cherny RA et al (2002) Overexpression of Alzheimer\u2019s disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277(47):44670\u201344676","journal-title":"J Biol Chem"},{"issue":"7","key":"136_CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"issue":"5254","key":"136_CR22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1126\/science.271.5254.1406","volume":"271","author":"G Multhaup","year":"1996","unstructured":"Multhaup G, Schlicksupp A, Hesse L, Beher D et al (1996) The amyloid precursor protein of Alzheimer\u2019s disease in the reduction of copper(II) to copper(I). Science 271(5254):1406\u20131409","journal-title":"Science"},{"issue":"1","key":"136_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-2005-8103","volume":"8","author":"F Pajonk","year":"2005","unstructured":"Pajonk F, Kessler H, Supprian T, Hamzei P et al (2005) Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer\u2019s disease. J Alzheimers Dis 8(1):23\u201327","journal-title":"J Alzheimers Dis"},{"issue":"24","key":"136_CR24","doi-asserted-by":"crossref","first-page":"14193","DOI":"10.1073\/pnas.2332851100","volume":"100","author":"AL Phinney","year":"2003","unstructured":"Phinney AL, Drisaldi B, Lugowski S, Schmidt S et al (2003) In vivo reduction of amyloid A\u00df by a mutant copper transporter. Proc Natl Acad Sci USA 100(24):14193\u201314198","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"136_CR25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60(12):1685\u20131691","journal-title":"Arch Neurol"},{"issue":"4","key":"136_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00109-006-0140-7","volume":"85","author":"S Sch\u00e4fer","year":"2007","unstructured":"Sch\u00e4fer S, Pajonk FG, Multhaup G, Bayer TA (2007) Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. J Mol Med 85(4):405\u2013413","journal-title":"J Mol Med"},{"issue":"19","key":"136_CR27","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1073\/pnas.1832769100","volume":"100","author":"DL Sparks","year":"2003","unstructured":"Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 100(19):11065\u201311069","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"136_CR29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.59.8.1153","volume":"59","author":"R Squitti","year":"2002","unstructured":"Squitti R, Lupoi D, Pasqualetti P, Dal Forno G et al (2002) Elevation of serum copper levels in Alzheimer\u2019s disease. Neurology 59(8):1153\u20131161","journal-title":"Neurology"},{"issue":"12","key":"136_CR30","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1212\/01.WNL.0000068013.27968.29","volume":"60","author":"R Squitti","year":"2003","unstructured":"Squitti R, Pasqualetti P, Cassetta E, Dal Forno G et al (2003) Elevation of serum copper levels discriminates Alzheimer\u2019s disease from vascular dementia. Neurology 60(12):2013\u20132014","journal-title":"Neurology"},{"issue":"5","key":"136_CR28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archneur.61.5.738","volume":"61","author":"R Squitti","year":"2004","unstructured":"Squitti R, Cassetta E, Dal Forno G, Lupoi D et al (2004) Copper perturbation in 2 monozygotic twins discordant for degree of cognitive impairment. Arch Neurol 61(5):738\u2013743","journal-title":"Arch Neurol"},{"key":"136_CR31","doi-asserted-by":"crossref","unstructured":"Strozyk D, Launer LJ, Adlard PA, Cherny RA et al (2007) Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging 10.1016\/j.neurobiolaging.2007.10.012","DOI":"10.1016\/j.neurobiolaging.2007.10.012"},{"issue":"50","key":"136_CR32","doi-asserted-by":"crossref","first-page":"51958","DOI":"10.1074\/jbc.M407410200","volume":"279","author":"C Treiber","year":"2004","unstructured":"Treiber C, Simons A, Strauss M, Hafner M et al (2004) Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer\u2019s disease. J Biol Chem 279(50):51958\u201351964","journal-title":"J Biol Chem"},{"issue":"6","key":"136_CR33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ajcn\/79.6.1037","volume":"79","author":"JR Turnlund","year":"2004","unstructured":"Turnlund JR, Jacob RA, Keen CL, Strain JJ et al (2004) Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men. Am J Clin Nutr 79(6):1037\u20131044","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"136_CR34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(99)01861-2","volume":"842","author":"AR White","year":"1999","unstructured":"White AR, Reyes R, Mercer JF, Camakaris J et al (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842(2):439\u2013444","journal-title":"Brain Res"},{"issue":"2","key":"136_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000052775","volume":"47","author":"J Wiltfang","year":"2001","unstructured":"Wiltfang J, Esselmann H, Maler JM, Bleich S et al (2001) Molecular biology of Alzheimer\u2019s dementia and its clinical relevance to early diagnosis and new therapeutic strategies. Gerontology 47(2):65\u201371","journal-title":"Gerontology"},{"issue":"3","key":"136_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A et al (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81(3):481\u2013496","journal-title":"J Neurochem"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0136-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:44:00Z","timestamp":1589042640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0136-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,30]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0136-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,30]]}}}